Fluorine-19 MRI signal phenotype in solid tumor following in situ perfluorocarbon cell labeling

Researchers have validated the use of fluorine-19 MRI and perfluorocarbon nanoemulsions to track myeloid-lineage immune cells in tumors. This noninvasive imaging technique allows for the quantification of tumor-associated macrophages, which are linked to cancer progression and immunotherapy resistance.
Why it matters
This provides a new, noninvasive biomarker for monitoring tumor microenvironments, potentially improving the efficacy of cancer immunotherapies.
Scientific Reports ( 2026 ) Cite this article
Scientific reporting on medical research methodology.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in